View in EDS

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.

Saved in:
Bibliographic Details
Title: Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
Authors: Roozendaal R; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands. RRoozend@its.jnj.com., Hendriks J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., van Effelterre T; Janssen R&D, Beerse, Belgium., Spiessens B; Janssen R&D, Beerse, Belgium., Dekking L; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Solforosi L; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Czapska-Casey D; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Bockstal V; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Stoop J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Splinter D; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.; argenx BV, Gent, Belgium., Janssen S; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Baelen BV; Janssen R&D, Beerse, Belgium.; BVB Clin Consult BVBA, Mechelen, Belgium., Verbruggen N; Janssen R&D, Beerse, Belgium.; Galapagos NV, Mechelen, Belgium., Serroyen J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Dekeyster E; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Volkmann A; Bavarian Nordic, Munich, Germany., Wollmann Y; Bavarian Nordic, Munich, Germany.; FGK Clinical Research, Munich, Germany., Carrion R Jr; Texas Biomedical Research Institute, San Antonio, TX, USA., Giavedoni LD; Texas Biomedical Research Institute, San Antonio, TX, USA., Robinson C; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Leyssen M; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Douoguih M; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Luhn K; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Pau MG; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Sadoff J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Vandebosch A; Janssen R&D, Beerse, Belgium., Schuitemaker H; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Zahn R; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Callendret B; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
Source: NPJ vaccines [NPJ Vaccines] 2020 Dec 17; Vol. 5 (1), pp. 112. Date of Electronic Publication: 2020 Dec 17.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33335092
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Roozendaal+R%22">Roozendaal R</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands. RRoozend@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Hendriks+J%22">Hendriks J</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Effelterre+T%22">van Effelterre T</searchLink>; Janssen R&D, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Spiessens+B%22">Spiessens B</searchLink>; Janssen R&D, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Dekking+L%22">Dekking L</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Solforosi+L%22">Solforosi L</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Czapska-Casey+D%22">Czapska-Casey D</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bockstal+V%22">Bockstal V</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Stoop+J%22">Stoop J</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Splinter+D%22">Splinter D</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.; argenx BV, Gent, Belgium.<br /><searchLink fieldCode="AU" term="%22Janssen+S%22">Janssen S</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Baelen+BV%22">Baelen BV</searchLink>; Janssen R&D, Beerse, Belgium.; BVB Clin Consult BVBA, Mechelen, Belgium.<br /><searchLink fieldCode="AU" term="%22Verbruggen+N%22">Verbruggen N</searchLink>; Janssen R&D, Beerse, Belgium.; Galapagos NV, Mechelen, Belgium.<br /><searchLink fieldCode="AU" term="%22Serroyen+J%22">Serroyen J</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dekeyster+E%22">Dekeyster E</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Volkmann+A%22">Volkmann A</searchLink>; Bavarian Nordic, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Wollmann+Y%22">Wollmann Y</searchLink>; Bavarian Nordic, Munich, Germany.; FGK Clinical Research, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Carrion+R+Jr%22">Carrion R Jr</searchLink>; Texas Biomedical Research Institute, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Giavedoni+LD%22">Giavedoni LD</searchLink>; Texas Biomedical Research Institute, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Robinson+C%22">Robinson C</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Leyssen+M%22">Leyssen M</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Douoguih+M%22">Douoguih M</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Luhn+K%22">Luhn K</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Pau+MG%22">Pau MG</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sadoff+J%22">Sadoff J</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vandebosch+A%22">Vandebosch A</searchLink>; Janssen R&D, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Schuitemaker+H%22">Schuitemaker H</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Zahn+R%22">Zahn R</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Callendret+B%22">Callendret B</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2020 Dec 17; Vol. 5 (1), pp. 112. <i>Date of Electronic Publication: </i>2020 Dec 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33335092
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41541-020-00261-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 112
    Titles:
      – TitleFull: Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Roozendaal R
      – PersonEntity:
          Name:
            NameFull: Hendriks J
      – PersonEntity:
          Name:
            NameFull: van Effelterre T
      – PersonEntity:
          Name:
            NameFull: Spiessens B
      – PersonEntity:
          Name:
            NameFull: Dekking L
      – PersonEntity:
          Name:
            NameFull: Solforosi L
      – PersonEntity:
          Name:
            NameFull: Czapska-Casey D
      – PersonEntity:
          Name:
            NameFull: Bockstal V
      – PersonEntity:
          Name:
            NameFull: Stoop J
      – PersonEntity:
          Name:
            NameFull: Splinter D
      – PersonEntity:
          Name:
            NameFull: Janssen S
      – PersonEntity:
          Name:
            NameFull: Baelen BV
      – PersonEntity:
          Name:
            NameFull: Verbruggen N
      – PersonEntity:
          Name:
            NameFull: Serroyen J
      – PersonEntity:
          Name:
            NameFull: Dekeyster E
      – PersonEntity:
          Name:
            NameFull: Volkmann A
      – PersonEntity:
          Name:
            NameFull: Wollmann Y
      – PersonEntity:
          Name:
            NameFull: Carrion R Jr
      – PersonEntity:
          Name:
            NameFull: Giavedoni LD
      – PersonEntity:
          Name:
            NameFull: Robinson C
      – PersonEntity:
          Name:
            NameFull: Leyssen M
      – PersonEntity:
          Name:
            NameFull: Douoguih M
      – PersonEntity:
          Name:
            NameFull: Luhn K
      – PersonEntity:
          Name:
            NameFull: Pau MG
      – PersonEntity:
          Name:
            NameFull: Sadoff J
      – PersonEntity:
          Name:
            NameFull: Vandebosch A
      – PersonEntity:
          Name:
            NameFull: Schuitemaker H
      – PersonEntity:
          Name:
            NameFull: Zahn R
      – PersonEntity:
          Name:
            NameFull: Callendret B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 12
              Text: 2020 Dec 17
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2059-0105
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ vaccines
              Type: main
ResultId 1